Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

(2011) K.-H. Chang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Systems pathology

(2010) Michael J. Donovan et al.   CANCER

Novel targets for prostate cancer chemoprevention

(2010) Fazlul H Sarkar et al.   ENDOCRINE-RELATED CANCER

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

(2010) Matei Andreoiu et al.   HUMAN PATHOLOGY

Mimickers of Prostatic Intraepithelial Neoplasia

(2010) Jonathan I. Epstein   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Metabolic alterations and targeted therapies in prostate cancer

(2010) Richard Flavin et al.   JOURNAL OF PATHOLOGY

Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells

(2010) L Sauer et al.   ONCOGENE

Organ-wide telomeric status in diseased and disease-free prostatic tissues

(2010) Christopher M. Heaphy et al.   PROSTATE

Is EGR1 a potential target for prostate cancer therapy?

(2009) Delphine Gitenay et al.   Future Oncology

Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer

(2009) Toshiro Migita et al.   JNCI-Journal of the National Cancer Institute

Evidence for field cancerization of the prostate

(2009) Larisa Nonn et al.   PROSTATE

Telomere DNA Content in Prostate Biopsies Predicts Early Rise in Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer

(2009) Eric G. Treat et al.   UROLOGY

Cost-effectiveness of prostate cancer chemoprevention

(2008) Robert S. Svatek et al.   CANCER

Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1

(2008) E. Furuta et al.   CANCER RESEARCH

Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer

(2008) Michelangelo Fiorentino et al.   LABORATORY INVESTIGATION